These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34250946)

  • 21. Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies.
    D'Amico A; Longo A; Fattori F; Tosi M; Bosco L; Chiarini Testa MB; Paglietti MG; Cherchi C; Carlesi A; Mizzoni I; Bertini E
    Orphanet J Rare Dis; 2021 Oct; 16(1):425. PubMed ID: 34641930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome.
    Lo SH; Lloyd A; Marshall J; Vyas K
    Clin Ther; 2021 Nov; 43(11):1861-1876.e16. PubMed ID: 34774333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical phenotype of X-linked myotubular myopathy in Labrador Retriever puppies.
    Snead EC; Taylor SM; van der Kooij M; Cosford K; Beggs AH; Shelton GD
    J Vet Intern Med; 2015 Jan; 29(1):254-60. PubMed ID: 25581576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy.
    Neese JM; Yum S; Matesanz S; Raffini LJ; Whitworth HB; Loomes KM; Mayer OH; Alcamo AM
    Neuromuscul Disord; 2021 Jul; 31(7):651-655. PubMed ID: 34120822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus study.
    Beggs AH; Byrne BJ; De Chastonay S; Haselkorn T; Hughes I; James ES; Kuntz NL; Simon J; Swanson LC; Yang ML; Yu ZF; Yum SW; Prasad S
    Muscle Nerve; 2018 Apr; 57(4):550-560. PubMed ID: 29149770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle function in a canine model of X-linked myotubular myopathy.
    Grange RW; Doering J; Mitchell E; Holder MN; Guan X; Goddard M; Tegeler C; Beggs AH; Childers MK
    Muscle Nerve; 2012 Oct; 46(4):588-91. PubMed ID: 22987702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
    Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
    Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory motor function in individuals with centronuclear myopathies.
    Smith BK; Renno MS; Green MM; Sexton TM; Lawson LA; Martin AD; Corti M; Byrne BJ
    Muscle Nerve; 2016 Feb; 53(2):214-21. PubMed ID: 26351754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons.
    Lawlor MW; Beggs AH; Buj-Bello A; Childers MK; Dowling JJ; James ES; Meng H; Moore SA; Prasad S; Schoser B; Sewry CA
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):102-10. PubMed ID: 26823526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy.
    Snyder JM; Meisner A; Mack D; Goddard M; Coulter IT; Grange R; Childers MK
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):131-7. PubMed ID: 26086764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions.
    Matza LS; Boye KS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Health Qual Life Outcomes; 2014 Apr; 12():48. PubMed ID: 24716709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression analyses in X-linked myotubular myopathy.
    Noguchi S; Fujita M; Murayama K; Kurokawa R; Nishino I
    Neurology; 2005 Sep; 65(5):732-7. PubMed ID: 16157907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
    Robb SA; Sewry CA; Dowling JJ; Feng L; Cullup T; Lillis S; Abbs S; Lees MM; Laporte J; Manzur AY; Knight RK; Mills KR; Pike MG; Kress W; Beeson D; Jungbluth H; Pitt MC; Muntoni F
    Neuromuscul Disord; 2011 Jun; 21(6):379-86. PubMed ID: 21440438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-linked myotubular myopathy in a family of two infant siblings: A case report and review.
    Koe AS; Tan YY; Vora S
    Pediatr Neonatol; 2024 Jul; ():. PubMed ID: 39013721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia.
    Kruger E; Aggio D; de Freitas H; Lloyd A
    Pharmacoecon Open; 2023 Jul; 7(4):627-638. PubMed ID: 37039966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV-Mediated Gene Transfer Restores a Normal Muscle Transcriptome in a Canine Model of X-Linked Myotubular Myopathy.
    Dupont JB; Guo J; Renaud-Gabardos E; Poulard K; Latournerie V; Lawlor MW; Grange RW; Gray JT; Buj-Bello A; Childers MK; Mack DL
    Mol Ther; 2020 Feb; 28(2):382-393. PubMed ID: 31784415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-linked myotubular and centronuclear myopathies.
    Pierson CR; Tomczak K; Agrawal P; Moghadaszadeh B; Beggs AH
    J Neuropathol Exp Neurol; 2005 Jul; 64(7):555-64. PubMed ID: 16042307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
    Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
    Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy.
    Hammans SR; Robinson DO; Moutou C; Kennedy CR; Dennis NR; Hughes PJ; Ellison DW
    Neuromuscul Disord; 2000 Feb; 10(2):133-7. PubMed ID: 10714588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.